Working… Menu

Gene Therapy for Achromatopsia (CNGB3) (CNGB3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03001310
Recruitment Status : Active, not recruiting
First Posted : December 23, 2016
Last Update Posted : September 13, 2019
EMAS Pharma
Syne Qua Non Limited
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 8, 2019
Estimated Study Completion Date : December 8, 2019